Phibro Animal Health Interim Results for the 6 -6-
February 11 2010 - 2:00AM
UK Regulatory
| capital leases | | | | | | | |
+-----------------------------------+-----------------------+--------+----------------------+--------+-----------------------+--------+----------------------+
| Equity transaction costs | | | | | | | (1,401) |
| | - | | - | | - | | |
+-----------------------------------+-----------------------+--------+----------------------+--------+-----------------------+--------+----------------------+
| | Net cash provided (used) | 2,687 | | (101) | | 379 | | 11,767 |
| | by financing activities | | | | | | | |
+--------+--------------------------+-----------------------+--------+----------------------+--------+-----------------------+--------+----------------------+
| Effect of exchange rate changes | 33 | | (476) | | 157 | | (597) |
| on cash | | | | | | | |
+-----------------------------------+-----------------------+--------+----------------------+--------+-----------------------+--------+----------------------+
| | Net increase (decrease) | 51,984 | | (4,703) | | 53,883 | | (2,101) |
| | in cash and cash | | | | | | | |
| | equivalents | | | | | | | |
+--------+--------------------------+-----------------------+--------+----------------------+--------+-----------------------+--------+----------------------+
| Cash and cash equivalents at | 15,417 | | 9,596 | | 13,518 | | 6,994 |
| beginning of period | | | | | | | |
+-----------------------------------+-----------------------+--------+----------------------+--------+-----------------------+--------+----------------------+
| Cash and cash equivalents at end | $ | | $ | | $ | | $ |
| of period | 67,401 | | 4,893 | | 67,401 | | 4,893 |
+-----------------------------------+-----------------------+--------+----------------------+--------+-----------------------+--------+----------------------+
| | | | | | | | | | | |
+--------+--------+--------+--------+-----------------------+--------+----------------------+--------+-----------------------+--------+----------------------+
| Supplemental cash flow | | | | | | | |
| information | | | | | | | |
+-----------------------------------+-----------------------+--------+----------------------+--------+-----------------------+--------+----------------------+
| | Interest paid | $ | | $ | | $ | | $ |
| | | 1,318 | | 392 | | 15,611 | | 13,889 |
+--------+--------------------------+-----------------------+--------+----------------------+--------+-----------------------+--------+----------------------+
| | Income taxes paid | (3,425) | | 1,555 | | (3,088) | | 4,076 |
| | (refunds received), net | | | | | | | |
+--------+--------------------------+-----------------------+--------+----------------------+--------+-----------------------+--------+----------------------+
| Non-cash investing and financing | | | | | | | |
| activities | | | | | | | |
+-----------------------------------+-----------------------+--------+----------------------+--------+-----------------------+--------+----------------------+
| | Capital lease additions | | | 476 | | 313 | | 476 |
| | | - | | | | | | |
+--------+--------+--------+--------+-----------------------+--------+----------------------+--------+-----------------------+--------+----------------------+
The table below reconciles net income (loss) to ebitda and adjusted ebitda:
+--------+--------+----------+------------------+--------+------------------+--------+------------------+--------+------------------+
| | | | Three months | | Six months |
+--------+--------+----------+----------------------------------------------+--------+----------------------------------------------+
| For the periods ended | 2009 | | 2008 | | 2009 | | 2008 |
| December 31 | | | | | | | |
+----------------------------+------------------+--------+------------------+--------+------------------+--------+------------------+
| | | | (in thousands) |
+--------+--------+----------+------------------------------------------------------------------------------------------------------+
| Net income (loss) | $ | | $ | | $ | | $ |
| | 32,549 | | (8,860) | | 41,533 | | (17,586) |
+----------------------------+------------------+--------+------------------+--------+------------------+--------+------------------+
| Plus | | | | | | | |
+----------------------------+------------------+--------+------------------+--------+------------------+--------+------------------+
| | Loss from | | | | | | | |
| | discontinued | | | | | | | |
| | operations, | | | | | | | |
+--------+-------------------+------------------+--------+------------------+--------+------------------+--------+------------------+
| | | net of | 1,098 | | 1,156 | | 1,217 | | 1,772 |
| | | income | | | | | | | |
| | | taxes | | | | | | | |
+--------+--------+----------+------------------+--------+------------------+--------+------------------+--------+------------------+
| | Gain on | | | | | | | |
| | disposal of | | | | | | | |
| | discontinued | | | | | | | |
| | operations, | | | | | | | |
+--------+-------------------+------------------+--------+------------------+--------+------------------+--------+------------------+
| | | net of | (28,488) | | | | (29,859) | | |
| | | income | | | - | | | | - |
| | | taxes | | | | | | | |
Phibro Animal S (LSE:PAHC)
Historical Stock Chart
From Jun 2024 to Jul 2024
Phibro Animal S (LSE:PAHC)
Historical Stock Chart
From Jul 2023 to Jul 2024